Arthur Rosenthal

Arthur Rosenthal

Director/Board Member chez PROFOUND MEDICAL CORP.

Fortune : 147 569 $ au 31/03/2024

77 ans
Health Technology
Consumer Services
Finance

Profil

Arthur L.
Rosenthal
founded Geyecue Medical Systems Ltd.
in 2011, where he is working as Chief Executive Officer from 2011 and EyeCue, Inc. in 2011, where he worked as Chief Executive Officer from 2011 to 2015.
Dr. Rosenthal also currently works at Arch Biosurgery, Inc., as Chairman from 2011, Interface Biologics, Inc., as Chairman from 2011, Profound Medical Corp., as Independent Director from 2018, and Boston University College of Engineering, as Professor from 2010.
Dr. Rosenthal also formerly worked at Cappella, Inc., as President & Chief Executive Officer from 2009 to 2011, Labcoat Ltd., as Chairman & Chief Executive Officer from 2005 to 2008, ArraVasc Ltd., as Executive Vice Chairman from 2011 to 2012, LivaNova USA, Inc., as Independent Non-Executive Director in 2015, HydroCision, Inc., as Director, Ultimate Finance Holdings Ltd., as Non-Executive Director from 2000 to 2010, Tornado Medical Systems, Inc., as Director from 2011 to 2012, Renovo Ltd., as Non-Executive Director from 2000 to 2010, Arch Therapeutics, Inc., as Director, Arch Therapeutics, Inc., as Independent Director from 2011 to 2015, LivaNova Plc, as Independent Director from 2015 to 2022, Arch Technologies, Inc., as Non-Executive Director from 2013 to 2015, Advent International LP, as Venture Advisor from 2005 to 2007, C.
R.
Bard, Inc. (New Jersey), as Vice President-Research & Development, Boston Scientific Corp., as Chief Scientific Officer & Senior Vice President from 1994 to 2005, Davol, Inc., as Vice President from 1982 to 1991, Pfizer Ltd., as Chief Scientific Officer, and Johnson & Johnson Medical, Inc., as Vice President-Research & Development.
Dr. Rosenthal received his undergraduate degree from the University of Connecticut and doctorate degree in 1973 from the University of Massachusetts.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
06/04/2023 17 300 ( 0,07% ) 147 569 $ 31/03/2024

Postes actifs de Arthur Rosenthal

SociétésPosteDébut
PROFOUND MEDICAL CORP. Director/Board Member 14/06/2018
Boston University College of Engineering Corporate Officer/Principal 01/06/2010
Arch Biosurgery, Inc. Chairman 01/04/2011
Geyecue Medical Systems Ltd. Chief Executive Officer 01/12/2011
Chairman 01/04/2011
Tous les postes actifs de Arthur Rosenthal

Anciens postes connus de Arthur Rosenthal

SociétésPosteFin
LIVANOVA PLC Director/Board Member 13/06/2022
CYBERONICS, INC. Director/Board Member 18/10/2015
ARCH THERAPEUTICS, INC. Director/Board Member 28/05/2015
Arch Technologies, Inc. Director/Board Member 01/05/2015
░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Arthur Rosenthal

Formation de Arthur Rosenthal

University of Connecticut Undergraduate Degree
University of Massachusetts Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Arthur Rosenthal

Relations

99

Relations au 1er degré

26

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
BOSTON SCIENTIFIC CORPORATION

Distribution Services

ARCH THERAPEUTICS, INC.

Distribution Services

LIVANOVA PLC

Health Technology

PROFOUND MEDICAL CORP.

Health Technology

Entreprise privées19

Finance

Health Technology

Health Technology

Health Technology

Finance

Arch Biosurgery, Inc.

Health Technology

Tornado Medical Systems, Inc.

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Arch Therapeutics, Inc. /Old/

Health Technology

Geyecue Medical Systems Ltd.

Arch Technologies, Inc.

EyeCue, Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Arthur Rosenthal